Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Boostrix versus Chinese DT booster vaccination in healthy children aged 6 to 8 years
2016-000644-34Phase 3
- Sponsor
- GSK
- Start
- Jun 2016
- Modality
- Vaccines & Immunotherapeutics, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial in diphtheria, Tetanus and pertussis comparing Boostrix booster with Chinese DT vaccine booster (2 arms). Primary endpoint: Anti-diphtheria toxoid antibody concentration at least 0.1 IU/mL.
02
Drugs
acellular pertussis vaccinediphtheria and tetanus toxoids vaccine
03
Conditions
diphtheriaTetanuspertussis
Beyond the preview
Go deeper on 2016-000644-34.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2016-000644-34.